Swiss Transplant Cohort Study
Launched by UNIVERSITY OF ZURICH · Sep 16, 2010
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
The Swiss Transplant Cohort Study is a research project that looks at all patients in Switzerland who have received solid organ or stem cell transplants since May 2008. The goal of this study is to gather important information about how these transplants affect patients over time, focusing on issues like immune system responses, infections, and the emotional and social aspects of living with a transplant. Researchers will collect various types of samples and data from participants to help improve future transplant care.
If you or a family member have had an organ or stem cell transplant, you might be eligible to participate in this study, as long as you provide your consent to join. Participants can expect to share their medical information regularly and may have samples taken for research purposes. This study is ongoing and welcomes individuals of all ages and genders, aiming to understand and enhance the overall experience and outcomes for transplant patients in Switzerland.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • All patients after organ and stem cell (planned 2009) transplantation.
- Exclusion criteria:
- • No informed consent given
About University Of Zurich
The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, , Switzerland
Patients applied
Trial Officials
01 Studienregister MasterAdmins
Study Director
UniversitaetsSpital Zuerich
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials